Jonsson Comprehensive Cancer Center: all 398 studies

Page 1 of 4. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.

• Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney CancerNot yet recruitingNCT07716735Phase 1
• Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit PatientsNot yet recruitingNCT07714421Phase 1
• Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT TrialNot yet recruitingNCT07671768Not applicable
• Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial CancerNot yet recruitingNCT07634601Phase 2
• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic CancerRecruitingNCT07619313Phase 1
• STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck DissectionNot yet recruitingNCT07612293Not applicable
• RAD ONC FREEDOM Oncology PainRecruitingNCT07605546Not applicable
• A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO StudyNot yet recruitingNCT07517211
• Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic LeukemiaNot yet recruitingNCT07468916Phase 2
• Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate CancerRecruitingNCT07468903Not applicable
• Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma PatientsRecruitingNCT07461948Phase 3
• Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE TrialNot yet recruitingNCT07439484Not applicable
• Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation NecrosisRecruitingNCT07339085Not applicable
• Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung CancerRecruitingNCT07323641Phase 2
• Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast BiopsiesRecruitingNCT07310004Not applicable
• Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray TreatmentRecruitingNCT07293585Phase 3
• Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE TrialRecruitingNCT07276438Not applicable
• Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung AdenocarcinomaRecruitingNCT07235280Early Phase 1
• Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung CancerNot yet recruitingNCT07229339Phase 2
• Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI TrialRecruitingNCT07191717Phase 2
• An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.RecruitingNCT07185165Phase 2
• Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON TrialRecruitingNCT07164027Early Phase 1
• Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate AdenocarcinomaRecruitingNCT07150715Phase 2
• ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG TrialRecruitingNCT07089641Phase 1
• Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing ToxicityRecruitingNCT07077239
• A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin CancerNot yet recruitingNCT07032701Not applicable
• Ivonescimab for the Treatment of Thymic CancerRecruitingNCT06980077Phase 2
• A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult PatientsRecruitingNCT06934239Phase 4
• Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)RecruitingNCT06810778Phase 1/2
• Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsRecruitingNCT06650163Phase 1
• Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)RecruitingNCT06572423Not applicable
• A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health CentersRecruitingNCT06568016Not applicable
• External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical CancerRecruitingNCT06543576Phase 1/2
• Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical CancersRecruitingNCT06538337Not applicable
• PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With GlioblastomaNot yet recruitingNCT06448286Phase 3
• An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney CancerRecruitingNCT06447103Phase 2
• Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)RecruitingNCT06436612Phase 2
• Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE TrialRecruitingNCT06432036Phase 1/2
• Improving Colonoscopy Surveillance for Patients With High Risk Colon PolypsRecruitingNCT06376565Not applicable
• Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA TrialRecruitingNCT06288113Phase 2
• Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal CancerRecruitingNCT06225011Phase 1
• Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)RecruitingNCT06216249Phase 2
• Prevention of Frailty With Fisetin and Exercise in Breast Cancer SurvivorsRecruitingNCT06113016Phase 2
• Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable GlioblastomaRecruitingNCT06090903Not applicable
• Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE TrialRecruitingNCT06067269Phase 2
• An Organoid-based Functional Precision Medicine Trial in OsteosarcomaRecruitingNCT06064682
• Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma CellsRecruitingNCT06059690Phase 1/2
• Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible ParticipantsRecruitingNCT05978128Not applicable
• Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial CancerRecruitingNCT05775471Phase 2
• Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaRecruitingNCT05688215Phase 1/2
• Fisetin to Improve Physical Function in Stage I-III Breast Cancer SurvivorsRecruitingNCT05595499Phase 2
• An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung CancerRecruitingNCT05558904Phase 1/2
• Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand TherapyRecruitingNCT05398302Phase 1
• Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell LymphomaRecruitingNCT05256641Phase 1/2
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaRecruitingNCT04945642Not applicable
• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate CancerRecruitingNCT04857502Early Phase 1
• Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer ClassificationRecruitingNCT04765150
• Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid CancerRecruitingNCT04742608
• Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal CancerRecruitingNCT04703101Phase 1
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerRecruitingNCT04553770Phase 2
• Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial CancerRecruitingNCT04469764Phase 2
• A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell TransplantRecruitingNCT04453072Not applicable
• Brain Health in Breast Cancer SurvivorsRecruitingNCT04297020
• Pembrolizumab in Treating Participants With LeukoplakiaRecruitingNCT03603223Phase 2
• Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion CohortRecruitingNCT02701153Not applicable
• Germ-Line Mutations in Blood and Saliva Samples From Patients With CancerRecruitingNCT02280161
• Active Surveillance for Cancer of the Prostate (ASCaP)RecruitingNCT00949819
• Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateActive, not recruitingNCT03582475Phase 1Results posted
• Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing SurgeryCompletedNCT03202472Not applicableResults posted
• Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung CancerCompletedNCT02879994Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryCompletedNCT02830165Not applicableResults posted
• Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural MesotheliomaTerminatedNCT02672033Not applicableResults posted
• Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver MetastasesTerminatedNCT02336763Not applicableResults posted
• Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT01635283Phase 2Results posted
• Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung CancerTerminatedNCT01532362Not applicableResults posted
• Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)TerminatedNCT01029925Phase 2Results posted
• Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01013285Phase 2Results posted
• Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00998010Phase 2Results posted
• Study of Gene Modified Immune Cells in Patients With Advanced MelanomaCompletedNCT00910650Phase 2Results posted
• Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by SurgeryTerminatedNCT00880542Phase 2Results posted
• Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing SurgeryCompletedNCT00685516Not applicableResults posted
• Rosiglitazone in Treating Patients With Pituitary TumorsTerminatedNCT00616642Phase 2Results posted
• Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)TerminatedNCT00612066Phase 2Results posted
• Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV MelanomaCompletedNCT00471887Phase 2Results posted
• Bortezomib in Treating Patients With Metastatic Kidney CancerCompletedNCT00276614Phase 2Results posted
• Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaCompletedNCT00182637Phase 2Results posted
• Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple MyelomaCompletedNCT00084747Phase 1/2Results posted
• Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast CancerCompletedNCT00068341Phase 2Results posted
• Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With SurgeryCompletedNCT00049322Phase 2Results posted
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00049257Phase 2Results posted
• Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu OverexpressionCompletedNCT00033514Phase 1/2Results posted
• Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing ChemoradiotherapyActive, not recruitingNCT07242365Phase 2
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
• Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION TrialActive, not recruitingNCT06995053Not applicable
• Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine NeoplasmsActive, not recruitingNCT06788938Phase 2
• Registry of Patients Undergoing Cryoablation for Early Stage Breast CancerActive, not recruitingNCT06387173
• A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric GliomaActive, not recruitingNCT06342908Phase 1
• Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic CancerActive, not recruitingNCT06090916Not applicable
• Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority GroupsActive, not recruitingNCT06090643Not applicable
• MR Correlated Spectroscopic Imaging for Diagnosing Breast CancerCompletedNCT06090630Early Phase 1

← Jonsson Comprehensive Cancer Center overview and focus areas